B+
Bull case
25%
Probability
Target price
$49.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
GRDN
Guardian Pharmacy ServicesCNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Positive operating momentum is supported by raised guidance, 23% first-half adjusted EBITDA growth, resident growth, geographic expansion, and reported cash of $89.8 million with no long-term debt outstanding under the credit facility. [#SEC-8K-2026-08-06]
Posture
Mixed
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +7.0.
What can break
Analyst consensus, target-revision data, and a clean direct-peer set are unavailable.
Momentum
83
Value
55
Sentiment
59
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $43.00 · Bull $49.00 · Bear $33.00Analysis 2026-09-03; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-22 • Model: HYBRID_IC_RP
AI Memo
As of 2026-09-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-22
Investment thesis
As of 2026-09-22
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-22. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $49.86
Why
Momentum83 · Δ7d +24.5
Value55 · Δ7d -0.0
Sentiment59 · Δ7d +7.0
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +7.0.
Contradictions & invalidation
- • Analyst consensus, target-revision data, and a clean direct-peer set are unavailable.
- • Execution risk remains around the Wellness Concepts integration, Lexington greenfield launch, and newly implemented regional leadership structure.
- • Reported revenue growth remains constrained by IRA pricing changes, and Q2 net income included an $8.5 million payor-dispute settlement, limiting the quality of earnings comparison.
Catalyst clock
2026-08-06
Q2 execution and raised FY2026 guidance
Lead driver: Sentiment · See AI snapshot
Momentum
83
9% active weight
Current posture
7d trendFlat
Δ7d
+24.5
Δ21d
+66.1
Value
55
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
-0.1
Sentiment
59
62% active weight
Current posture
7d trendImproving
Δ7d
+7.0
Δ21d
-38.7
Why this grade
Composite grade C. Momentum 82.7 / Value 55.3 / Sentiment 58.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-09-03. Scenario method
Most likely
B
Base case
55%
Probability
Target price
$43.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
B-
Bear case
20%
Probability
Target price
$33.00
Analysis reference price unavailable
Analysis 2026-09-03 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.41B
Beta
-
Shares Out
63.34M
P/E (TTM) · Derived
48.2
P/S (TTM)
-
P/FCF (TTM) · Derived
30.31
Rev YoY
+2.2%
EPS YoY
+139.7%
Gross Margin
+21.6%
Op Margin
+5.7%
Net Debt
-$20.9M
Current Ratio
1.65
As of 2026-09-22 • Updated nightlySource: Internal modelMethods & Data